Oct 28, 2020
Mark Campbell, Vice President, Clinical Solutions RxBenefits on their technology-enabled prescription benefits services being offered to self-funded employer groups who are managing their own benefits. COVID-19 has driven changes in enrollment and demand for services as well changing the number of prescriptions and...
Oct 28, 2020
Mark Campbell, Vice President, Clinical Solutions RxBenefits on their technology-enabled prescription benefits services being offered to self-funded employer groups who are managing their own benefits. COVID-19 has driven changes in enrollment and demand for services as well changing the number of prescriptions and...
Oct 27, 2020
Dr. Nishi Rawat, Senior Vice President, Appriss Health and Co-Founder OpenBeds shines a light on the challenges of finding appropriate substance abuse disorder and mental health treatment especially in light of the additional challenges from COVID-19. Instead of a clinician facing network, development of a consumer...
Oct 27, 2020
Dr. Nishi Rawat, Senior Vice President, Appriss Health and Co-Founder OpenBeds shines a light on the challenges of finding appropriate substance abuse disorder and mental health treatment especially in light of the additional challenges from COVID-19. Instead of a clinician facing network, development of a consumer...
Oct 26, 2020
Rahul Aras, CEO, Iterion Therapeutics, describes their lead product Tegavivint, a potent selective inhibitor of nuclear beta-catenin, a high-value oncology target because of its role in cell proliferation, differentiation, immune evasion and other aspects of cancer development. An early clinical study in patients with...